D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
676
DELISTED
Apollo Global Management Series A
APO.PRA
| $54.4M | 0.03% |
895,000
+125,000
| +16% | +$8.1M |
2024 Q3
7 quarters
|
|
677
HCA Healthcare
HCA
$102B
| $54.4M | 0.03% |
139,447
+89,512
| +179% | +$37.8M |
2021 Q2
20 quarters
|
|
678
Williams Companies
WMB
$87.7B
| $54.4M | 0.03% |
731,245
-1,217,304
| -62% | -$89.6M |
2020 Q4
22 quarters
|
|
679
Elevance Health
ELV
$95.4B
| $54.3M | 0.03% |
140,324
-265,668
| -65% | -$98.5M |
2014 Q4
46 quarters
|
|
680
CALL
argenx
ARGX
$54.9B
| $54.1M | 0.03% |
58,300
-17,800
| -23% | -$14.7M |
2023 Q3
11 quarters
|
|
681
Amkor Technology
AMKR
$9.8B
| $53.9M | 0.03% |
624,860
-863,905
| -58% | -$61.6M |
2024 Q2
8 quarters
|
|
682
Butterfly Network
BFLY
$1.8B
| $53.8M | 0.03% |
6,392,827
+5,272,536
| +471% | +$27.3M |
2025 Q4
2 quarters
|
|
683
PUT
BCE
BCE
$19B
| $53.7M | 0.03% |
2,494,000
-150,000
| -6% | -$3.6M |
2023 Q4
10 quarters
|
|
684
CALL
Newmont
NEM
$113B
| $53.6M | 0.03% |
574,100
+302,900
| +112% | +$33M |
2021 Q3
19 quarters
|
|
685
GSK
GSK
$102B
| $53.4M | 0.03% |
+1,019,449
| New | +$53.9M |
2026 Q2
0 quarters
|
|
686
Snowflake
SNOW
$115B
| $53.4M | 0.03% |
209,813
+59,360
| +39% | +$10.9M |
2023 Q1
13 quarters
|
|
687
PUT
Intuit
INTU
$91.8B
| $53.4M | 0.03% |
204,500
+128,400
| +169% | +$44.7M |
2021 Q3
19 quarters
|
|
688
ConocoPhillips
COP
$181B
| $53.3M | 0.03% |
513,089
+79,272
| +18% | +$9.4M |
2022 Q2
16 quarters
|
|
689
Novavax
NVAX
$1.6B
| $53.2M | 0.03% |
5,650,905
-2,058,953
| -27% | -$18.4M |
2023 Q3
11 quarters
|
|
690
Stifel
SF
$10B
| $53.2M | 0.03% |
762,408
+140,024
| +22% | +$10.4M |
2014 Q1
49 quarters
|
|
691
Textron
TXT
$13.2B
| $53M | 0.03% |
578,134
-310,680
| -35% | -$28.2M |
2017 Q2
36 quarters
|
|
692
Pebblebrook Hotel Trust
PEB
$2.3B
| $53M | 0.03% |
2,728,760
+1,872,055
| +219% | +$28.9M |
2018 Q4
30 quarters
|
|
693
PUT
Chipotle Mexican Grill
CMG
$34.8B
| $52.5M | 0.03% |
1,545,000
+476,500
| +45% | +$15.6M |
2013 Q2
52 quarters
|
|
694
Ralliant Corp
RAL
$7.36B
| $52.4M | 0.02% |
711,817
+634,147
| +816% | +$35.4M |
2025 Q2
4 quarters
|
|
695
LyondellBasell Industries
LYB
$21.5B
| $52.1M | 0.02% |
990,499
+908,268
| +1,105% | +$62.7M |
2025 Q3
3 quarters
|
|
696
CALL
TeraWulf
WULF
$5.65B
| $52.1M | 0.02% |
2,110,000
-1,410,000
| -40% | -$32.4M |
2025 Q3
3 quarters
|
|
697
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $52M | 0.02% |
328,794
-1,038,998
| -76% | -$140M |
2025 Q4
2 quarters
|
|
698
NovaGold Resources
NG
$2.64B
| $51.8M | 0.02% |
8,684,037
-850,580
| -9% | -$7.08M |
2024 Q4
6 quarters
|
|
699
CALL
Rogers Communications
RCI
$17.5B
| $51.8M | 0.02% |
1,595,000
-250,000
| -14% | -$9.02M |
2023 Q2
12 quarters
|
|
700
Kosmos Energy
KOS
$1.71B
| $51.8M | 0.02% |
24,538,308
+4,152,563
| +20% | +$11.6M |
2024 Q3
7 quarters
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.